Retour
Fourchette du Jour
20,55 €
21,72 €
Fourchette 52 Semaines
12,56 €
26,30 €
Volume
173 346
Moyenne 50J / 200J
18,41 €
/
16,37 €
Clôture Précédente
20,93 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -19,9 | 0,3 |
| P/B | 18,0 | 2,9 |
| ROE % | -74,5 | 3,7 |
| Net Margin % | -20794,6 | 3,8 |
| Rev Growth 5Y % | -29,5 | 10,0 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Hold
30,00 €
+40.9%
BPA Prévisionnel
-1,18 €
CA Est.
3,2 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
0,39 €
0,32 € – 0,46 €
|
180 M | 1 |
| FY2029 |
-0,31 €
-0,37 € – -0,25 €
|
94 M | 1 |
| FY2028 |
-0,79 €
-0,94 € – -0,64 €
|
41 M | 1 |
Points Clés
Revenue declined -29,51% annually over 5 years
Debt/Equity of 0,09 — conservative balance sheet
Negative free cash flow of -54,44M
Capital intensive — 90,00% of revenue goes to capex
Croissance
Revenue Growth (5Y)
-29,51%
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-74,45%
ROIC-65,43%
Net Margin-20794,57%
Op. Margin-21982,57%
Sécurité
Debt / Equity
0,09
Current Ratio10,53
Interest Coverage0,00
Valorisation
P/E Ratio
-19,89
P/B Ratio17,95
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -29,51% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 350 000,0 | Net Income (TTM) | -72,78M |
| ROE | -74,45% | ROA | -75,72% |
| Gross Margin | -360,00% | Operating Margin | -21982,57% |
| Net Margin | -20794,57% | Free Cash Flow (TTM) | -54,44M |
| ROIC | -65,43% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,09 | Current Ratio | 10,53 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -19,89 | P/B Ratio | 17,95 |
| P/S Ratio | 4135,68 | PEG Ratio | -0,73 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,45B | Enterprise Value | 1,37B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 350 000,0 | 0,0 | 0,0 | 700 000,0 | 1,42M |
| Net Income | -72,78M | -53,59M | -42,21M | -58,51M | -63,66M |
| EPS (Diluted) | -1,08 | -0,92 | -0,88 | -1,72 | -2,28 |
| Gross Profit | -1,26M | 0,0 | -1,21M | -11,24M | -550 000,0 |
| Operating Income | -76,94M | -56,26M | -43,57M | -58,06M | -63,01M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 96,11M | 132,46M | 59,15M | 77,88M | 54,25M |
| Total Liabilities | 15,46M | 17,60M | 14,79M | 80,13M | 18,56M |
| Shareholders' Equity | 80,66M | 114,86M | 44,36M | -2,25M | 35,69M |
| Total Debt | 7,53M | 8,90M | 9,14M | 75,96M | 11,25M |
| Cash & Equivalents | 80,74M | 118,04M | 44,37M | 61,14M | 28,61M |
| Current Assets | 83,42M | 119,45M | 45,33M | 62,15M | 36,63M |
| Current Liabilities | 7,92M | 10,06M | 6,71M | 5,98M | 8,52M |